Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), sold 100,000 shares at $114.01 ($11.4M) on 2023-07-27, disclosed to the SEC on 2023-07-28.
Scheduled sale ($11.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.43 | 20,934 | $2.4M | 20.9% |
| 2 | $113.43 | 20,934 | $2.4M | 20.9% |
| 3 | $114.01 | 29,066 | $3.3M | 29.1% |
| 4 | $114.01 | 29,066 | $3.3M | 29.1% |
| Total | $113.77 avg | 100,000 | $11.4M | 100% |
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |
| ABT | SELL | 2022-10-31 | $9.7M | — | Filing → |